CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-01 | Shanahan Karin EVP, Glob. Prod. Dev. & Supply | Grant or award · Restricted Stock Units | +18,843 | 18,843 | ||
| 2024-11-01 | Meyers Gregory Scott EVP, Chief Digital & Tech Off. | Grant or award · Restricted Stock Units | +18,843 | 18,843 | ||
| 2024-11-01 | BOERNER CHRISTOPHER S. Chief Executive Officer | Option exercise | +2,964 | 104,169 | ||
| 2024-11-01 | BOERNER CHRISTOPHER S. Chief Executive Officer | Other disposition | −55 | 104,114 | ||
| 2024-11-01 | BOERNER CHRISTOPHER S. Chief Executive Officer | Shares withheld for taxes | −1,488 | $54.32 | $81K | 102,626 |
| 2024-11-01 | BOERNER CHRISTOPHER S. Chief Executive Officer | Option exercise · Market Share Units | −2,964 | 8,894 | ||
| 2024-11-01 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Purchase | +1,830 | $54.68 | $100K | 62,109 |
| 2024-10-02 | Gallman Cari EVP, Corporate Affairs | Option exercise | +4,558 | 6,667 | ||
| 2024-10-02 | Gallman Cari EVP, Corporate Affairs | Shares withheld for taxes | −1,648 | $53.76 | $89K | 5,019 |
| 2024-10-02 | Gallman Cari EVP, Corporate Affairs | Option exercise · Restricted Stock Units | −4,558 | 9,117 | ||
| 2024-09-30 | YALE PHYLLIS R Director | Grant or award · Deferred Share Units | +676.46 | $51.74 | $35K | 29,847.87 |
| 2024-09-30 | Samuels Theodore R. II Director | Grant or award · Deferred Share Units | +966.37 | $51.74 | $50K | 51,297.97 |
| 2024-09-30 | Rice Derica W Director | Grant or award · Deferred Share Units | +724.78 | $51.74 | $38K | 25,892.23 |
| 2024-09-30 | McMullen Michael R. Director | Grant or award · Deferred Share Units | +603.98 | $51.74 | $31K | 3,628.13 |
| 2024-09-30 | Bhatt Deepak Director | Grant or award · Deferred Share Units | +169.12 | $51.74 | $9K | 10,696.09 |
| 2024-09-30 | Arduini Peter J Director | Grant or award · Deferred Share Units | +652.3 | $51.74 | $34K | 55,577.68 |
| 2024-08-01 | Gallman Cari EVP, Corporate Affairs | Option exercise | +1,061 | 2,493 | ||
| 2024-08-01 | Gallman Cari EVP, Corporate Affairs | Shares withheld for taxes | −384 | $48.17 | $18K | 2,109 |
| 2024-08-01 | Gallman Cari EVP, Corporate Affairs | Option exercise · Restricted Stock Units | −1,061 | 2,122 | ||
| 2024-07-29 | McMullen Michael R. Director | Other disposition · Call Option (obligation to sell) | −5 | 0 |
Page 28 of 40 · 799 trades